Results 31 to 40 of about 141,022 (304)

Hormonal replacement therapy, prothrombotic mutations and the risk of venous thrombosis [PDF]

, 2002
Hormone replacement therapy (HRT) increases the risk of venous thrombosis. We investigated whether this risk is affected by carriership of hereditary prothrombotic abnormalities.
A. Rumley, Anderson, Bloemenkamp, Daly, E. Daly, F. M. Helmerhorst, F. R. Rosendaal, G. D. O. Lowe, Grady, Grodstein, Hulley, Jick, Kniffin, Lowe, M. Vessey, M. Woodward, Mehta, Nordström, Oger, Rees, Rosendaal, Rosendaal, Silverstein, Stadel, Vandenbroucke, Vessey, Woolf   +26 more
core   +1 more source

IMPLANTATION OF SUPERIOR VENA CAVA FILTERS

Неотложная медицинская помощь, 2018
The purpose of this review is to evaluate the results of superior vena cava filters placement in order to prevent pulmonary embolism associated with upper extremities deep vein thrombosis.
S. A. Prozorov
doaj   +1 more source

The aetiology of deep venous thrombosis [PDF]

QJM, 2006
Most ideas about the pathogenesis of deep venous thrombosis (DVT) are dominated by a 'consensus model' first articulated around 1962. This model invokes 'Virchow's triad' and attributes thrombogenesis in veins to some combination of 'hypercoagulability', 'stasis' and 'intimal injury'.
P C, Malone, P S, Agutter
openaire   +2 more sources

Cancer and thrombosis: Managing the risks and approaches to thromboprophylaxis [PDF]

, 2006
Patients with cancer are at increased risk of venous thromboembolism (VTE) compared with patients without cancer. This results from both the prothrombotic effects of the cancer itself and iatrogenic factors, such as chemotherapy, radiotherapy, indwelling
Altinbas M, Athanasoulis CA, Bergqvist D, Bergqvist D, Buller HR, Clagett PG, Da Silva MS, Decousus H, ENOXACAN Study Group, Falanga A, Geerts WH, Gitter MJ, Goldenberg N, Gomes MPV, Green D, Haas S, Heit JA, Hettiarachchi RJK, Hull R, Hutten BA, International Multicentre Trial, Johnson MJ, Kakkar VV, Karthaus M, Koopman MMW, Levine MN, Mousa S A, Mousa SA, Prandoni P, Rasmussen MS, Rickles FR, Sallah S, Samama M, Siragusa B, The Columbus Investigators, White RH, Zacharski LR   +36 more
core   +1 more source

Venous Thromboembolism Within Professional American Sport Leagues. [PDF]

, 2017
Background: Numerous reports have described players in professional American sports leagues who have been sidelined with a deep vein thrombosis (DVT) or a pulmonary embolism (PE), but little is known about the clinical implications of these events in ...
Astolfi, Matthew, Bishop, Meghan, Deluca, Peter F., Hammoud, Sommer, Padegimas, Eric M.   +4 more
core   +2 more sources

DVT Surveillance Program in the ICU: Analysis of Cost-Effectiveness [PDF]

, 2014
Background Venous Thrombo-embolism (VTE – Deep venous thrombosis (DVT) and/or pulmonary embolism (PE) – in traumatized patients causes significant morbidity and mortality.
Aboutanos, Michel B., Borchers, Todd C., Duane, Therese M., Goldberg, Stephanie R., Ivatury, Rao R., Khiatani, Vishal, Levy, Mark M., Malhotra, Ajai K., Martin, Nancy R., McLay, Laura, Wolfe, Luke G.   +10 more
core   +3 more sources

Thrombolysis for deep venous thrombosis [PDF]

Journal of Vascular Surgery, 2012
The key questions addressed in this summary are whether clot removal should be part of the preferred therapy for patients with acute deep venous thrombosis (DVT), and whether there is evidence that a strategy of thrombus removal offers better outcomes for patients than anticoagulation alone.
openaire   +2 more sources

Consensus among Chinese experts on standard interventional therapy for deep venous thrombosis of lower extremity (second edition)

Journal of Interventional Medicine, 2018
: This is an update on the first edition of the expert consensus. This document discusses the indications and contraindications of interventional treatment methods for deep venous thrombosis such as anticoagulation, catheter-directed thrombolysis ...
Jianping Gu, Ke Xu, Gaojun Teng
doaj   +1 more source

Predictive factors of venous recanalization in upper-extremity vein thrombosis.

PLoS ONE, 2021
BackgroundUpper extremity venous thrombosis (UEVT) represents about 10% of venous thrombo-embolic disease. This is mainly explained by the increasing use of central venous line, for oncologic or nutritional care.
Gaëtan Ploton, Nicolas Brebion, Béatrice Guyomarch, Marc-Antoine Pistorius, Jérôme Connault, Jeanne Hersant, Alizée Raimbeau, Guillaume Bergère, Mathieu Artifoni, Cécile Durant, Giovanni Gautier, Romain Dumont, Jean-Manuel Kubina, Claire Toquet, Olivier Espitia   +14 more
doaj   +1 more source

Cancer-Associated Thrombosis in Cirrhotic Patients with Hepatocellular Carcinoma. [PDF]

, 2018
It is common knowledge that cancer patients are more prone to develop venous thromboembolic complications (VTE). It is therefore not surprising that patients with hepatocellular carcinoma (HCC) present with a significant risk of VTE, with the portal vein
Burra, P, Campello, E, Russo, Fp., Simioni, P, Spiezia, L, Zanetto, A   +5 more
core   +1 more source